Changeflow GovPing Healthcare & Life Sciences Download Excel Data on EU Medicine Authorisations
Routine Notice Added Final

Download Excel Data on EU Medicine Authorisations

Favicon for www.ema.europa.eu EMA Medicines - Full Catalogue
Detected
Email

Summary

EMA offers downloadable Excel data tables with detailed information on centrally authorised medicines, covering approved medicines, withdrawn marketing authorisation applications, post-authorisation procedure opinions, referrals, paediatric investigation plans, orphan designations, periodic safety update report single assessments (PSUSAs), direct healthcare professional communications (DHPCs), medicine supply shortages, herbal medicines, and medicines for use outside the EU. The website automatically updates these data tables overnight. Data includes information on medicines for which the European Commission has refused, suspended, or withdrawn a marketing authorisation.

Published by EMA on ema.europa.eu . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EMA Medicines - Full Catalogue for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 2 changes logged to date.

What changed

EMA provides downloadable Excel tables containing comprehensive regulatory data on EU medicines, including approved medicines, withdrawn applications, post-authorisation procedure opinions, referrals, paediatric investigation plans, orphan designations, PSUSAs, DHPCs, supply shortages, herbal medicines, and medicines for use outside the EU. The tables are publicly accessible and automatically updated overnight.

Healthcare professionals, pharmaceutical companies, patients, and regulatory researchers can use these tables to access structured data on medicine marketing authorisations, safety communications, and supply chain information. The data is informational and does not create new compliance obligations.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Download medicine data

You can download tables with detailed data on medicines from this page. This includes information on marketing authorisations of centrally authorised medicines and post-authorisation procedures. Human Veterinary Herbal Medicines

You can download data related to medicines published on EMA's website in table format. The website automatically updates these data tables overnight.

To stay up-to-date with new and updated information on this website, see:

Medicines

Find the following types of information on medicines in the table below:

  • Approved medicines
  • Withdrawn applications for new marketing authorisations
  • Status of opinions
    Download medicines data table All relevant information and documents on medicines authorised at a European Union (EU) level are available on medicine pages. This includes:

  • Full scientific assessment reports

  • Public-friendly overviews in question-and-answer format

  • Package leaflets
    These pages also contain information on medicines for which the European Commission has refused a marketing authorisation, or has suspended or withdrawn the marketing authorisation after approval.

More up-to-date information on veterinary medicinal products is available on the Veterinary Medicines Information website.

For more information, see:

Post-authorisation procedures for medicines

Find information on opinions on post-authorisation procedures and withdrawn applications in the table below.

Download post-authorisation procedures for medicines data table During the post-authorisation stage of a medicine life-cycle, marketing authorisation holders can submit an application to change the terms of marketing authorisation. This is known as a variation.

At any stage of the assessment process, applicants can withdraw the application to EMA.

Information on approved post-authorisation procedures is available on medicine pages.

For more information, see:

Referrals

Find information on all ongoing and completed referrals in the table below.

Download referrals data table For more information, see:

Paediatric investigation plans

Find information on decisions related to paediatric investigation plans following evaluation from the Paediatric Committee (PDCO) in the table below.

Download paediatric investigation plans data table For more information, see:

Orphan designations

Find information on the status of orphan designations following assessment from the Committee for Orphan Medicinal Products (COMP) in the table below.

Download orphan designations data table For more information, see:

Periodic safety update report single assessments (PSUSAs)

Find information on the regulatory outcomes of periodic safety update report single assessments (PSUSAs) in the table below.

Download period safety update report single assessments data table Marketing authorisation holders periodically submit PSURs following a medicine's authorisation. EMA and national competent authorities carry out a single joint assessment of all medicines containing the same active substance or combination of active substances to determine if there is a need to update marketing authorisations.

For more information, see:

Direct healthcare professional communications (DHPCs)

Find information on direct healthcare professional communication (DHPCs) for human and veterinary medicines in the table below. These contain important new safety information about a medicine, including recommended actions that healthcare professionals should take.

Download direct healthcare professional communications data table For more information, see:

Medicine supply shortages

Find information on ongoing and resolved medicine supply shortages assessed by EMA in the table below. The table includes links to individual shortage notices that contain valuable information for healthcare professionals and patients, along with details on the availability of alternatives.

Download medicine supply shortages data table For each shortage, additional information about the situation in a specific country may be available from the national competent authority.

For more information, see:

Herbal medicines

Find information on the status and outcomes of assessments from EMA's Committee on Herbal Medicinal Products (HMPC) in the table below.

Download herbal medicines data table For more information, see:

Medicines for use outside EU

Find information on the status of EMA's scientific opinions on high priority medicines for use outside of the EU in the table below.

Download medicines for use outside EU data table For more information, see:

Maximum residue limits (MRLs)

Find information on maximum residue limits (MRLs) in the table below.

Download maximum residue limits (MRLs) data table For more information, see:

  • Maximum residue limits (MRLs) JSON data format files EMA’s entire website is available in JSON format for automated use. For medicines and related procedures, the data provided is identical to that provided in the tables on this page.

Check our JSON data files

Page update history

An update log is available to show the date and summary of changes to this webpage. It does not include updates to linked documents or minor edits like typos or broken link fixes.

The tracking of updates begins in April 2026.

See update history

10 April 2026

Maximum residue limits (MRLs) section added

Related documents

Product information URLs for member states

English (EN) (703 KB - XLS)

First published:

27/09/2018

Last updated:

22/04/2026

View

Related content

Share this page

Get daily alerts for EMA Medicines - Full Catalogue

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EMA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EMA
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Data download Regulatory information access
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Public Health Medical Devices Healthcare

Get alerts for this source

We'll email you when EMA Medicines - Full Catalogue publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!